PL
CCXI

Parkwood LLC’s ChemoCentryx, Inc. CCXI Stock Holding History

Parkwood LLC’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-52,660
Closed -$705K – 138
2021
Q2 		$705K Buy
52,660
+37,102
+238% +$914K 0.08% 102
2021
Q1 		$797K Sell
15,558
-1,885
-11% -$113K 0.14% 79
2020
Q4 		$1.08M Sell
17,443
-11,817
-40% -$677K 0.13% 89
2020
Q3 		$2.09M Buy
29,260
+5,613
+24% +$302K 0.32% 67
2020
Q2 		$1.36M Buy
+23,647
New +$1.29M 0.24% 70

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Parkwood LLC's CCXI Position: Q3 2021 in Review

Parkwood LLC sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 52,660 shares — an estimated $705K sold.

Parkwood LLC first reported a position in CCXI in Q2 2020 and held it in 5 quarters. The position peaked at $2.09M in Q3 2020. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Parkwood LLC reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Parkwood LLC sold 52,660 ChemoCentryx, Inc. shares in Q3 2021, an estimated $705K.
  • Parkwood LLC first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 5 quarters.
  • Parkwood LLC's ChemoCentryx, Inc. position peaked at $2.09M in Q3 2020.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Parkwood LLC's 13F filing for Q3 2021, filed 12 Nov 2021.